CLINICAL_TRIALS
trial_result
· 2025-09-18
Clinical Trial Update: FSHD Molecular Characterization
Summary
The clinical trial NCT06096441, studying molecular characterization of facioscapulohumeral muscular dystrophy, has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nationwide Children's Hospital | Conditions: Facio-Scapulo-Humeral Dystrophy | Status: TERMINATED